GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study

Trial Profile

GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Oxaliplatin (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Acronyms GASTRICHIP
  • Most Recent Events

    • 20 Jan 2016 Planned End Date changed from 1 May 2021 to 1 May 2023 as reported by ClinicalTrials.gov.
    • 20 Jan 2016 Planned primary completion date changed from 1 May 2021 to 1 May 2023 as reported by ClinicalTrials.gov.
    • 13 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top